Table 2 Costs and clinical outcomes for women under each prevention strategy*
From: Modeling optimal cervical cancer prevention strategies in Nigeria
Scenario investigated | Annual cost for 100,000 women (per 1 Woman)** | Annual CC cases for 100,000 women |
|---|---|---|
No prevention | $26,201 ($0.26) | 17.45 |
One lifetime screening | $75,418 ($0.75) | 12.15 |
Vaccination (3 doses) | $191,415 ($1.91) | 6.01 |
Vaccination (3 doses) and one lifetime screening | $238,580 ($2.39) | 4.25 |
Two lifetime screenings (sensitivity analysis only) | $115,082 ($1.15) | 9.63 |
Three lifetime screenings (sensitivity analysis only) | $145,316 ($1.45) | 7.85 |
Vaccination (3 doses) and two lifetime screenings (sensitivity analysis only) | $275,519 ($2.76) | 3.39 |
Vaccination (3 doses) and three lifetime screenings (sensitivity analysis only) | $303,324 ($3.03) | 2.74 |
Vaccination (2 doses) | $130,603 ($1.31) | 6.01 |
Vaccination (2 doses) and one lifetime screening | $177,775 ($1.78) | 4.25 |
Vaccination (2 doses) and two lifetime screenings (sensitivity analysis only) | $214,717 ($2.15) | 3.39 |
Vaccination (2 doses) and three lifetime screenings (sensitivity analysis only) | $242,523 ($2.43) | 2.74 |